VO Banner
Search: for Help
Vaxvec Home
News and Updates
Vaxvec Vectors
Vaxvec Vaccines
Vaxvec Antigens
VaxvecAg BLAST
Selected Vectors
B. abortus RB51 vector
RSV vaccine vector
SL3261 vaccine vector
VSV vaccine vector
Data Submission
Data Exchange
Data Download
Contact Us

Coxsackievirus vaccine vector

Vaxvec ID 58
Vaccine Vector Name Coxsackievirus vaccine vector
Vector VO ID VO_0001057
Related Vaccine(s)
Gu et al., 2010: Gu R, Shampang A, Nashar T, Patil M, Fuller DH, Ramsingh AI. Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responses. PloS one. 2010; 5(9); . [PubMed: 20824074].
Halim et al., 2000: Halim SS, Ostrowski SE, Lee WT, Ramsingh AI. Immunogenicity of a foreign peptide expressed within a capsid protein of an attenuated coxsackievirus. Vaccine. 2000; 19(7-8); 958-965. [PubMed: 11115722].
Henke et al., 2008: Henke A, Jarasch N, Wutzler P. Coxsackievirus B3 vaccines: use as an expression vector for prevention of myocarditis. Expert review of vaccines. 2008; 7(10); 1557-1567. [PubMed: 19053211].
Kim and Nam, 2010: Kim DS, Nam JH. Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines. Expert opinion on biological therapy. 2010; 10(2); 179-190. [PubMed: 20088713].
Kim and Nam, 2011: Kim DS, Nam JH. Application of attenuated coxsackievirus B3 as a viral vector system for vaccines and gene therapy. Human vaccines. 2011; 7(4); 410-416. [PubMed: 21389776].
Kim et al., 2010: Kim DS, Cho YJ, Kim BG, Lee SH, Nam JH. Systematic analysis of attenuated Coxsackievirus expressing a foreign gene as a viral vaccine vector. Vaccine. 2010; 28(5); 1234-1240. [PubMed: 19941986].
Slifka et al., 2001: Slifka MK, Pagarigan R, Mena I, Feuer R, Whitton JL. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection. Journal of virology. 2001; 75(5); 2377-2387. [PubMed: 11160741].